Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (10 ops.)
Latest filing published 05 Aug 2026 for Fate Therapeutics INC, €83k. Read the official filing
Filing timeline
BuySaleCindy Tahl
Insider track record
Disclosed buys
0
Disclosed sells
10
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Cindy Tahl: trading record in brief
All filings by Cindy Tahl on record concern Fate Therapeutics Inc, in the capacity of board member. We count 21 filings; the first trade dates from 8 January 2016 and the latest from 4 August 2026.
On the market, this insider has only sold: 10 sales, €804k in total. Besides market trades, the filings include 6 share grants and 5 option exercises. So far in 2026, the count stands at no purchases and 3 sales.
On 5 August 2026 came the latest disclosure, an open-market sale for €83k in Fate Therapeutics Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Cindy Tahl
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations21 total
38,800 shares@ US$2.45890.032% mcap4.8% of flowCommon StockSEC:0001193125-26-335019:0
25,590 shares@ US$1.8790.020% mcap1.6% of flowCommon StockSEC:0001193125-26-234390:0
100,000 shares0Common StockSEC:0001193125-26-015328:0
10,589 shares@ US$1.06480.6% of flowCommon StockSEC:0001193125-26-010356:0
9,037 shares@ US$1.05930.5% of flowCommon StockSEC:0000950170-25-102983:0
70,000 shares0Common StockSEC:0000950170-25-006311:0
5,654 shares@ US$1.550.3% of flowCommon StockSEC:0000950170-25-004823:0
200,000 shares0Common StockSEC:0000950170-24-088769:0
10,874 shares@ US$4.371.6% of flowCommon StockSEC:0000950170-24-003652:0
24,363 shares@ US$2.402.1% of flowCommon StockSEC:0001209191-23-054968:0
11,553 shares@ US$5.242.1% of flowCommon StockSEC:0001209191-23-002977:0
25,000 shares@ US$6.559.3% of flowCommon StockSEC:0001209191-22-033481:0
19,433 shares@ US$4.845.1% of flowCommon StockSEC:0001209191-22-022495:0
33,302 shares0Common StockSEC:0000899243-22-003424:0
4,883 shares@ US$48.4613.3% of flowCommon StockSEC:0001209191-22-003172:0
7,095 shares@ US$46.3718.5% of flowCommon StockSEC:0001209191-22-003051:0
50,000 shares@ US$6.5518.4% of flowCommon StockSEC:0001209191-22-000647:0
60,958 shares0Common StockSEC:0001209191-21-066163:0
50,000 shares@ US$6.5518.1% of flowCommon StockSEC:0001209191-21-058930:0
5,534 shares@ US$7.872.3% of flowCommon StockSEC:0001209191-21-045182:0
6,633 sharesCommon StockSEC:0001209191-16-091070:0
21 of 21 declarations
